Retail Hiring Surges in April as Consumer Warning Signs Emerge UK Chancellor Reeves Announces VAT Cut for Theme Parks and Childrens Meals to Ease CostofLiving Pressures Europe Faces Strategic Vulnerability as US Dominates Satellite and AI Infrastructure Warns Telecoms CEO Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines The Office Lunch Evolution From Luxury to Workplace Burden Novartis Upgrades FullYear Sales and Profit Guidance on Strong Operational Momentum NetSTREIT Corp NTST Q1 2026 Earnings EPS Misses Street View Shares Dip on Weaker Profitability Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds CBRE Q1 2026 Earnings Stellar EPS Beat Underscores Resilient Business Model CAR Q1 2026 Earnings Heavy EPS Miss Amplifies Concerns Around Fleet Costs BGS Q1 2026 Earnings Profit Beat Drives Caution Amid Revenue Disclosures Mineralys Therapeutics MLYS Sees Slight Decline Maintains Position Between Key Technical Levels Addentax Group Corp ATXG Slides Amid Weakness Support Levels in Focus Yorkville Acquisition Corp Warrant MCGAW Holds Steady at 036 as Investors Eye Key Support Zone Virco Manufacturing VIRC Holds Near Support After Minimal Gain TON Strategy Company TONX Rallies 62 as Price Approaches Key Resistance US Payrolls Surge Past Expectations in April Yet Report Signals Underlying Concerns Chime Financial CHYM Q1 2026 Earnings Massive EPS Beat Masks Broader Concerns as Stock Slides NOMADAR Corp NOMA Jumps 1491 Support and Resistance in Focus NewGenIvf Group NIVF Surges 51 Key Levels to Watch After Massive Move Incoming Ofcom Chair Ian Cheshire Vows to Take on Tech Bros Amid Online Safety Concerns Cal BanCorp BCAL Up 150 Is There More Room to Run 20260520 Sensus Healthcare SRTS Posts Weak Q1 2026 Misses on Both Top and Bottom Lines Market Digest NJR PRGO WWW UBER in Focus Amid Sector Movements Air T Inc Q1 2026 Earnings Positive EPS of 161 Reported with No Market Reaction Regeneron Shares Slide After Phase 3 Melanoma Trial Failure Market Weighs Pipeline Impact